Editorial
Going with the gut: probiotics as a novel therapy for hepatocellular carcinoma
Abstract
Hepatocellular carcinoma (HCC) is a leading cause of death worldwide (1). It is the most frequent primary liver tumor and usually occurs in patients affected by liver cirrhosis (1).
